162 related articles for article (PubMed ID: 9679697)
1. Lymphomatoid papulosis followed by Hodgkin's disease.
Silva MM; Morais JC; Spector N; Maceira J; Sousa MA; Filgueira AL
Int J Dermatol; 1998 Jul; 37(7):541-3. PubMed ID: 9679697
[No Abstract] [Full Text] [Related]
2. Lymphomatoid papulosis and Hodgkin's disease: report of a case.
Koeppel MC; Horschowski N; Terrier G; Andrac L; Stoppa AM; Signoret R; Sayag J
Dermatology; 1994; 189(2):188-92. PubMed ID: 7521232
[TBL] [Abstract][Full Text] [Related]
3. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
Sagar TG; Chandra A; Raman SG
Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
[No Abstract] [Full Text] [Related]
4. Hodgkin's lymphoma--the great teacher.
Connors JM
N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715
[No Abstract] [Full Text] [Related]
5. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Lopez M
Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
[No Abstract] [Full Text] [Related]
6. Hodgkin's disease: clinical presentation and treatment.
Tirelli U; Vaccher E; Spina M; Carbone A
Cancer Treat Res; 2001; 104():247-65. PubMed ID: 11191130
[No Abstract] [Full Text] [Related]
7. Greater curability in advanced Hodgkin's disease?
Portlock CS
Cancer J Sci Am; 1999; 5(5):264-5. PubMed ID: 10526665
[No Abstract] [Full Text] [Related]
8. Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
Diehl V
J Clin Oncol; 2003 Feb; 21(4):583-5. PubMed ID: 12586791
[No Abstract] [Full Text] [Related]
9. ABVD, the Stanford V regimen, and BEACOPP for Hodgkin's lymphoma: what should an oncologist do?
Connors JM
Clin Lymphoma; 2005 Jun; 6(1):50-1. PubMed ID: 15989708
[No Abstract] [Full Text] [Related]
10. [The practice of chemotherapy with the DeVita protocol].
Gassmann W; Schmitz N; Löffler H
Dtsch Med Wochenschr; 1982 Jul; 107(27):1063-9. PubMed ID: 6177488
[No Abstract] [Full Text] [Related]
11. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
12. Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.
Bruessow C; Karrer U; Gubler J; Pless M
J Clin Oncol; 2012 Apr; 30(12):e130-2. PubMed ID: 22393099
[No Abstract] [Full Text] [Related]
13. Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risks.
Klumb CE; Carriço MK; de Rezende LM; Byington R; Bordallo MA; Bigni RS; Apa AG; Dobbin JA
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):628-9. PubMed ID: 17662581
[No Abstract] [Full Text] [Related]
14. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
16. [Initial results of hybrid chemotherapy of Hodgkin's disease using COPP/VBA].
Schneider T; Molnár Z; Szántó I; Fleischmann T
Orv Hetil; 1992 Oct; 133(43):2755-7. PubMed ID: 1383907
[TBL] [Abstract][Full Text] [Related]
17. Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a single-center, retrospective study.
Belada D; Štěpánková P; Sýkorová A; Žák P; Smolej L
Leuk Lymphoma; 2015 Jul; 56(7):2013-8. PubMed ID: 25330440
[TBL] [Abstract][Full Text] [Related]
18. Drug selection in the treatment of Hodgkin's disease.
Bonadonna G; Santoro A
Hematol Oncol; 1983; 1(1):3-12. PubMed ID: 6203820
[No Abstract] [Full Text] [Related]
19. More is not necessarily better when treating Hodgkin's lymphoma.
Connors JM
J Clin Oncol; 2011 Nov; 29(32):4215-6. PubMed ID: 21990411
[No Abstract] [Full Text] [Related]
20. Escalated BEACOPP in advanced Hodgkin's lymphoma.
Casasnovas O; Coiffier B
Lancet; 2012 May; 379(9828):1767-8. PubMed ID: 22480757
[No Abstract] [Full Text] [Related]
[Next] [New Search]
